General discussion, page-17808

Bob and that US consortium did internal due diligence that we didn't have access to and got involved - thats what kept me around. Was in the green until February and obviously unhappy with the shareprice now.

Share price is as bad as other biotechs, but on the worse end of the spectrum. Their are definitely concerns with sud, but I'm not overly concerned with 1AI after looking into it. I'd be concerned if there was any significant transactions or business, but seems like a small company with an idea that Joels dad is supportive of.